Bukwang Pharmaceutical Co., Ltd. (KRX:003000)
South Korea · Delayed Price · Currency is KRW 3,640.00
+125.00 (3.56%)
At close: Oct 2, 2025
Bukwang Pharmaceutical Market Cap
Bukwang Pharmaceutical has a market cap or net worth of 358.65 billion as of October 6, 2025. Its market cap has increased by 7.03% in one year.
Market Cap
358.65B
Enterprise Value
299.73B
Revenue
179.16B
Ranking
n/a
PE Ratio
29.90
Stock Price
3,640.00
Market Cap Chart
Since August 29, 1995, Bukwang Pharmaceutical's market cap has increased from 63.76B to 358.65B, an increase of 462.53%. That is a compound annual growth rate of 5.90%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 2, 2025 | 358.65B | 14.14% |
| Dec 30, 2024 | 314.21B | -24.75% |
| Dec 28, 2023 | 417.57B | -30.29% |
| Dec 29, 2022 | 598.98B | -32.17% |
| Dec 30, 2021 | 883.07B | -54.11% |
| Dec 30, 2020 | 1,924.17B | 109.52% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 71.81T |
| Celltrion | 38.64T |
| ALTEOGEN | 25.22T |
| Yuhan | 8,969.60B |
| SK Biopharmaceuticals | 8,144.58B |
| Peptron | 7,006.86B |
| PharmaResearch | 5,714.31B |
| LigaChem Biosciences | 5,545.53B |